These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 8259596)

  • 1. Potential for transfusion-associated graft-versus-host disease due to apheresis platelets matched for HLA class I antigens.
    Grishaber JE; Birney SM; Strauss RG
    Transfusion; 1993; 33(11):910-4. PubMed ID: 8259596
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fatal graft-versus-host disease associated with transfusions of HLA-matched, HLA-homozygous platelets from unrelated donors.
    Benson K; Marks AR; Marshall MJ; Goldstein JD
    Transfusion; 1994 May; 34(5):432-7. PubMed ID: 8191569
    [TBL] [Abstract][Full Text] [Related]  

  • 3. HLA homozygosity and shared HLA haplotypes in the development of transfusion-associated graft-versus-host disease.
    Shivdasani RA; Anderson KC
    Leuk Lymphoma; 1994 Oct; 15(3-4):227-34. PubMed ID: 7866271
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A systematic review of transfusion-associated graft-versus-host disease.
    Kopolovic I; Ostro J; Tsubota H; Lin Y; Cserti-Gazdewich CM; Messner HA; Keir AK; DenHollander N; Dzik WS; Callum J
    Blood; 2015 Jul; 126(3):406-14. PubMed ID: 25931584
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transfusion-associated graft-versus-host disease in a patient treated with Cladribine (2-chlorodeoxyadenosine): demonstration of exogenous DNA in various tissue extracts by PCR analysis.
    Zulian GB; Roux E; Tiercy JM; Extermann M; Diebold-Berger S; Reymond JM; Helg C; Zubler R; Betticher DC; Alberto P
    Br J Haematol; 1995 Jan; 89(1):83-9. PubMed ID: 7833282
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transfusion-associated graft-versus-host disease in immunocompetent patients: report of a fatal case associated with transfusion of blood from a second-degree relative, and a survey of predisposing factors.
    Petz LD; Calhoun L; Yam P; Cecka M; Schiller G; Faitlowicz AR; Herron R; Sayah D; Wallace RB; Belldegrun A
    Transfusion; 1993 Sep; 33(9):742-50. PubMed ID: 8105567
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [One-way matching of HLA antigens between recipient and donor as a risk factor of transfusion-associated GVHD].
    Takahashi K
    Nihon Rinsho; 1997 Sep; 55(9):2240-5. PubMed ID: 9301283
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transfusion-associated graft-versus-host disease in a liver transplant recipient: an unusual presentation and review of the literature.
    O'Brien KL; Pereira SE; Wagner J; Shadman M; Hendrie P; Nelson K; Gernsheimer TB; Price T; Reyes JD; Nester T
    Transfusion; 2013 Jan; 53(1):174-80. PubMed ID: 22563807
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transfusion-associated graft-versus-host disease in an immunocompetent patient following cardiac surgery.
    Rososhansky S; Badonnel MC; Hiestand LL; Popovsky MA; Szymanski IO
    Vox Sang; 1999; 76(1):59-63. PubMed ID: 9933856
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Donor Immunization Against Human Leukocyte Class II Antigens is a Risk Factor for Graft-versus-Host Disease.
    Delbos F; Barhoumi W; Cabanne L; Beckerich F; Robin C; Redjoul R; Astati S; Toma A; Pautas C; Ansart-Pirenne H; Cordonnier C; Bierling P; Maury S
    Biol Blood Marrow Transplant; 2016 Feb; 22(2):292-299. PubMed ID: 26453972
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Transfusion-associated graft-versus-host disease. Increased risk when using HLA matched donors].
    Hovdenes J; Solheim BG
    Tidsskr Nor Laegeforen; 1995 May; 115(12):1499-501. PubMed ID: 7770854
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The impact of universal leukodepletion of the blood supply on hemovigilance reports of posttransfusion purpura and transfusion-associated graft-versus-host disease.
    Williamson LM; Stainsby D; Jones H; Love E; Chapman CE; Navarrete C; Lucas G; Beatty C; Casbard A; Cohen H
    Transfusion; 2007 Aug; 47(8):1455-67. PubMed ID: 17655590
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transfusion-associated graft-versus-host disease with transfusion practice in cardiac surgery.
    Yasuura K; Okamoto H; Matsuura A
    J Cardiovasc Surg (Torino); 2000 Jun; 41(3):377-80. PubMed ID: 10952326
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Multicenter analyses demonstrate significant clinical effects of minor histocompatibility antigens on GvHD and GvL after HLA-matched related and unrelated hematopoietic stem cell transplantation.
    Spierings E; Kim YH; Hendriks M; Borst E; Sergeant R; Canossi A; Oudshoorn M; Loiseau P; Dolstra H; Markiewicz M; Leffell MS; Pereira N; Kircher B; Turpeinen H; Eliaou JF; Gervais T; Laurin D; Enczmann J; Martinetti M; Thomson J; Oguz F; Santarone S; Partanen J; Siekiera U; Alessandrino EP; Kalayoglu S; Brand R; Goulmy E
    Biol Blood Marrow Transplant; 2013 Aug; 19(8):1244-53. PubMed ID: 23756210
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transfusion-associated GVHD after fludarabine therapy in a patient with systemic lupus erythematosus.
    Leitman SF; Tisdale JF; Bolan CD; Popovsky MA; Klippel JH; Balow JE; Boumpas DT; Illei GG
    Transfusion; 2003 Dec; 43(12):1667-71. PubMed ID: 14641861
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diagnosis of transfusion-associated graft-vs.-host disease: the importance of short tandem repeat analysis.
    Sage D; Stanworth S; Turner D; Navarrete C
    Transfus Med; 2005 Dec; 15(6):481-5. PubMed ID: 16359419
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High resolution HLA class I and II typing and CTLp frequency in unrelated donor transplantation: a single-institution retrospective study of 69 BMTs.
    El Kassar N; Legouvello S; Joseph CM; Salesses P; Rieux C; Cordonnier C; Vernant JP; Farcet JP; Bierling P; Kuentz M
    Bone Marrow Transplant; 2001 Jan; 27(1):35-43. PubMed ID: 11244436
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transfusion-associated graft-versus-host disease and the irradiation of blood components.
    Davey RJ
    Immunol Invest; 1995; 24(1-2):431-4. PubMed ID: 7713602
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Donor-Recipient Matching for KIR Genotypes Reduces Chronic GVHD and Missing Inhibitory KIR Ligands Protect against Relapse after Myeloablative, HLA Matched Hematopoietic Cell Transplantation.
    Faridi RM; Kemp TJ; Dharmani-Khan P; Lewis V; Tripathi G; Rajalingam R; Daly A; Berka N; Storek J; Masood Khan F
    PLoS One; 2016; 11(6):e0158242. PubMed ID: 27341514
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Graft-versus-host disease in rhabdomyosarcoma following transfusion with nonirradiated blood products.
    Labotka RJ; Radvany R
    Med Pediatr Oncol; 1985; 13(2):101-4. PubMed ID: 3856732
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.